Join
Live feed
·
INSIDERFilingvia Quantisnow
Wave Life Sciences Ltd. logo

Director Takanashi Ken was granted 12,700 units of Ordinary Shares, increasing direct ownership by 0.22% to 5,729,003 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
WVE· Wave Life Sciences Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WVE (Wave Life Sciences Ltd.) and more on Quantisnow.